This study reveals that the small molecule Camptothecin induces endogenous GDF15, suppressing food intake and reducing body weight in obese mice, suggesting a promising candidate for anti-obesity treatment. Here, GDF15 is linked to obesity due to melanocortin 4 receptor deficiency.